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Abstract
Background: Many low- and middle-income countries recommend micronutrient supplements for pregnant
women to improve their nutritional status, prevent possible deficiencies and avoid fetal healgth consequences. This
study evaluated the influence of socioeconomic status on the use of folic acid, iron salts and other vitamins and
minerals among pregnant women in the 2015 Pelotas Birth Cohort.
Methods: This population-based birth cohort study was carried out with 4270 women. Participants were
interviewed during pregnancy and at the maternity hospital about the antenatal period; including the use of iron
salts, vitamins and other minerals. Descriptive analyses were performed to characterize the sample. The analyses
were adjusted according to socioeconomic variables (maternal education, ethnicity, household income).
Results: The overall prevalence of the use of folic acid, iron salts or other vitamins and minerals was 91.0% (95% CI:
90.1–91.8). Specifically, 70.9% (95% CI: 69.5–72.3) used folic acid, 72.9% (95% CI: 71.5–74.3) used iron compounds,
and 31.8% (95% CI: 30.3–33.2) used other vitamins or minerals. In the adjusted analysis, the use of iron salts was
associated with nonwhite mothers, with ≤4 years of education and whose family income was less than or equal to
the monthly minimum wage. The use of folic acid and other vitamins and minerals was associated with white
mothers who were more highly educated and had a higher family income.
Conclusion: Although folic acid and other vitamins and minerals were more frequently used in white, richer and
more educated mothers, which indicates inequality, iron supplements were more frequently used in the poorer,
less educated nonwhite mothers, suggesting the opposite association for this supplement.
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Background
Micronutrient deficiencies are common among women
of reproductive age, and multiple supplements are often
indicated for pregnant women. These micronutrient
deficiencies may occur due to losses or malabsorption
associated with disease, inadequate intake, high fertility
rate, short intervals between pregnancies, lack of
knowledge about the importance of nutrition during the
antenatal period, pregnancy or physiological changes
that occur during pregnancy [1–3]. Thus, many low-
and middle-income countries recommend micronutrient
supplements for pregnant women to improve their
nutritional status, prevent possible deficiencies and avoid
fetal health consequences [1–5].
Although adequate food intake remains the preferred
means of meeting micronutrient requirements, some
micronutrient requirements are difficult to meet during
pregnancy through diet alone. The most important
micronutrients during pregnancy, which are commonly
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obtained in the form of supplements, include vitamins
A, C, D, and E; folic acid; iron; zinc; iodine; copper;
selenium; and the B vitamins [2, 4].
Supplementation during the antenatal period can
benefit both the mother and fetus [3]. Prophylactic use
of iron salts prevents anemia and reduces the risk of low
birth weight [6, 7]. Folic acid helps prevent neural tube
defects [8]. Iodine can prevent cretinism and aid in fetal
growth, as well as reduce the risk of stillbirths, miscar-
riages and anomalies [1]. Calcium is associated with
reduced risks of pre-eclampsia, low birth weight and
premature birth [1]. Supplementation with other min-
erals, such as copper, selenium, magnesium and zinc,
has also been shown to reduce labor complications and
contribute to fetal development [1, 2, 9].
In response to these needs, some countries fortify
selected foods and/or recommend the use of supple-
ments during the antenatal period [6]. The World
Health Organization (WHO) strongly recommends daily
oral iron and folic acid supplements as part of antenatal
care to reduce micronutrient deficiencies. Iron and folic
acid supplements should be taken throughout the preg-
nancy, and the supplementation should begin as soon as
possible, regardless of gestational age [6].
In Brazil, although almost all Brazilian pregnant
women attend at least one antenatal visit, the proportion
of women who attended six or more visits was 73% in
2012, and this percentage was lower in young women
with lower socioeconomic status and those who were
less educated [10, 11]. Additionally, receiving antenatal
care early in a pregnancy is common in only three-
quarters of women, with a lower prevalence in women
who are younger, black and from the North and North-
east regions of the country [11], consistently pointing
out socioeconomic inequalities in antenatal care [11, 12].
Despite the existence of health programs that recom-
mend supplementation as a component of antenatal
care, the literature indicates that the use of iron and folic
acid is lower than expected [5, 12–14]. Although some
studies have reported the use of supplements during
pregnancy, few have focused on socioeconomic inequal-
ity in their use [12, 15, 16], which is a very important
fact, especially in low- and middle-income countries
where there are diverse socioeconomic contexts [17].
Thus, the objective of this study was to analyze the
influence of socioeconomic status on the use of folic
acid, iron salts and other vitamins and minerals during
pregnancy.
Methods
This study is part of the Pelotas Birth Cohort of 2015
(C2015), which was conducted in the city of Pelotas in
southern Brazil. All women living in the urban area of
Pelotas who gave birth in the city’s five maternity wards
between January 1 and December 31, 2015 were invited
to participate. More details of the study can be found in
the cohort profile paper [18].
Mothers were interviewed at the maternity hospital a
few hours after delivery and responded to a standardized
questionnaire about the antenatal period, including the
use of folic acid, iron salts or other vitamins and min-
erals. The questionnaire applied was already used in a
similar way in other Pelotas birth cohort studies [19–21]
and is available on the website of the research center:
(http://www.epidemio-ufpel.org.br/uploads/downloads/
Perinatal.pdf ). In total, 4270 women were recruited
for the perinatal study, representing 98.7% of all
women in the eligible population [18].
A total of 75% of the women included in the perinatal
study were followed up since pregnancy, which allowed
us to qualify the information regarding the use of sup-
plements during this period.
The following questions (translated to English) were
used for the collection of data regarding supplement
use: “Have you used or are you using any vitamin,
calcium, folic acid, or iron salt supplements since you
became pregnant?” For each supplement reported, the
following questions were asked to characterize their
usage: “Why do/did you use it?” (routine/prevention,
anemia/deficiency, other), “How many days per week
do/did you use it?”, “Who told you to use it?” (a doctor
or nurse, another person or yourself ), and “In which
trimester/s did you use this supplement?” (first, second
or third).
The supplements were initially classified as folic acid,
iron salts or vitamins and other minerals. Those
containing iron salts were classified as isolated ferrous
sulfate, associations of iron, other isolated forms of iron,
and unspecified iron compounds. There was only one
subgroup for folic acid due to the recommended daily
allowance for pregnant women: folic acid associated with
vitamin E. Due to the low dosage, any other forms were
classified with the other groups.
The other vitamins and minerals were classified into
large groups: calcium carbonate, mineral supplements,
multivitamins (including vitamins only), vitamin D,
multivitamin and mineral supplements, and other
vitamins.
After classifying all supplement groups, it was possible
to generate the dependent variables “use of iron salts”,
“use of folic acid” and “use of other vitamins and
minerals”.
The independent variables that were analyzed were
maternal age (collected in complete years and catego-
rized as ≤19, 20–29, 30–46); ethnicity (self-reported by
mothers as white, black or other); parity (total number
of deliveries, including stillbirths and current pregnancy;
later categorized as 1, 2, 3 or 4 or more); mother’s
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schooling (number of years of study, later categorized
into four groups: 0–4, 5–8, 9–11 and 12 or more years)
and family income expressed in local currency and con-
verted into a multiple of minimum wage at the time of
the perinatal interview (categorized as ≤1, 1.1 to 3.0, 3.1
to 6.0, 6.1 to 10 and > 10). A ‘minimum wage’ is a meas-
ure of the legal minimum monthly salary for formal
employees in Brazil.
All deliveries were performed in one of five Pelotas
maternities (two medical school hospitals, one of them
exclusively for users of the Unified Health System
(SUS)).
Data analysis was performed using STATA®, version
12.1. The sample was initially described according to the
independent variables. Supplement use frequency was
then calculated according to the independent variables,
yielding the respective confidence intervals (95% CIs).
Crude and adjusted analyses using Poisson regression
with robust variance were carried out to verify whether
the use of iron, folic acid and other vitamins and min-
erals differed according to socioeconomic variables. All
socioeconomic variables (ethnicity, education and family
income) obtained a p value < 0.2 in the crude analysis,
so they were included in the adjusted analysis. A hetero-
geneity test and a linear trend test (ordinal variables)
were performed. The variables with a p value < 0.05 were
considered statistically significant.
To characterize the supplements, a stratified analysis
according to gestational trimester was performed. To
illustrate the absolute inequality between the use of these
supplements according to the trimester of use and family
income, we use an equiplot, a graph illustrating the fre-
quency of use of supplements by socioeconomic strata.
This study was approved by the Universidade Federal
de Pelotas School of Physical Education Ethics Commit-
tee (522.064) and was registered in the National Ministry
of Health’s Plataforma Brasil. All mothers signed a free
and informed consent form before being interviewed.
Results
Of the 4270 mothers who participated in C2015, 3886
(91.0, 95% CI, 90.1–91.8) reported using folic acid, iron
salts or other vitamins and minerals during pregnancy.
Of these, 70.9% (95% CI 69.5–72.3) used folic acid,
72.9% (95% CI 71.5–74.3) used some type of iron
compound and 30.3% (95% CI 30.3–33.2) used other vi-
tamins or minerals. Table 1 shows the sample character-
istics and prevalence of supplement use according to the
studied variables. The majority of the mothers were
white (70.5%), between 20 and 29 years of age (47.3%),
had 9 to 11 years of education (34.3%), had a family in-
come of 1.1–3.0-times the minimum wage (47.2%) and
were experiencing their first pregnancy (49.5%).
The use of folic acid, iron salts or other vitamins and
minerals was more frequent in the following groups:
white women, women between 30 and 46 years of age,
those with 12 years or more of schooling, those with a
family income over 10-times the minimum wage and
those who were experiencing their first pregnancy. How-
ever, the 95% CIs of these prevalence rates overlapped in
most categories (Table 1).
Considering the delivery hospitals, 46.4% of deliveries
occurred in private hospitals; 35.0% occurred in a school
hospital, which also attends private patients and accepts
health insurance; and 18.5% occurred in a SUS hospital.
Regarding the characteristics of supplement use ac-
cording to family income, the majority of supplement
use was recommended by doctors or nurses, although
iron and other vitamin and mineral supplements were
Table 1 Description of mothers participating in the 2015
Pelotas Birth Cohort perinatal study regarding the use of folic
acid, iron salts or other vitamins and minerals (N = 4270 women)
Folic acid, iron salts or other
vitamins and minerals
N % N % IC 95%
Ethnicity
White 3005 70.5 2765 92.0 91.0–93.0
Black 680 15.9 607 89.2 86.9–91.6
Other 578 13.5 510 88.2 85.6–90.9
Age (years)
< =19 years 630 14.7 556 88.3 85.7–90.8
20–29 2021 47.3 1839 91.0 89.7–92.2
30–46 1618 37.9 1490 92.1 90.8–93.4
Education (years)
0–4 years 394 9.2 321 81.5 77.6–85.3
5–8 1098 25.7 958 87.3 85.3–89.2
9–11 1463 34.3 1346 92.0 90.6–93.4
12 or more 1314 30.8 1261 96.0 94.9–97.0
Family Income (multiple of minimum wage)a
≤ 1 548 12.8 464 84.6 81.6–87.6
1.1–3.0 2015 47.2 1810 89.8 88.5–91.1
3.1–6.0 1126 26.4 1054 93.6 92.2–95.0
6.1–10.0 316 7.4 299 94.6 92.1–97.1
> 10.0 263 6.2 258 98.1 96.4–99.8
Parity
1 2114 49.5 1988 94.0 93.0–95.0
2 1315 30.8 1206 91.7 90.2–93.2
3 472 11.1 409 86.7 83.6–89.7
4 or more 367 8.6 282 76.8 72.5–81.2
Total 4270 100 3886 91.0 90.1–91.8
a monthly minimum wage in 2015 (R$788 or $201)
Pelotas, RS, Brazil, 2015
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recommended equally for both rich and poor women
(approximately 98%). Folic acid was recommended for
99.0% the poorest mothers, compared to 95.0% of the
richest mothers. Routine/prevention was the most com-
monly reported reason for using iron salts, and the
reasons were equally distributed between the richest and
the poorest mothers. For folic acid and other vitamins
and minerals, the most commonly reported reason for
use was routine/prevention (92.4 and 69.3%, respect-
ively), differing between rich (97.0 and 74.4%, respect-
ively) and poor mothers (87.0 and 62.3%, respectively).
Poor mothers more frequently cited deficiency, while
richer mothers reported the usage as routine (data not
shown in the table).
Folic acid use declined closer to delivery, falling from
62.0% in the first trimester (T1) to 15.2% in the third
trimester (T3) (Fig. 1). The opposite occurred with iron
salts; the use in T3 was 60.7%. The use of the other vita-
mins and minerals totaled 14.1% of all supplements in
T1 and 25.3% in T3. The frequency of the use of the
other vitamins and minerals was 13.0% in T1 and 23.2%
in T3.
Figure 2 shows the use of folic acid, iron salts and
other vitamins and minerals according to trimester and
family income. In the first trimester of pregnancy, folic
acid was more frequently used by the richest mothers
with family incomes between 6.1–10-times the mini-
mum wage (67.0%) and > 10-times the minimum wage
(77.6%). Iron salts were more frequently used in the
poorest mothers, regardless of the trimester. Other
vitamins and minerals were more frequently used in the
richest mothers (> 10-times the minimum wage) during
all trimesters (p < 0.005 for all values).
Table 2 describes the socioeconomic factors associated
with the use of folic acid and iron salts separately. In
both the crude and adjusted analyses, all variables were
significantly associated with both outcomes. In the ad-
justed analysis of folic acid use, black mothers used folic
acid 9.0% less than white mothers. Women with 4 years
or less of education used 22.0% less folic acid than those
who were better educated. The use of folic acid was
17.0% lower among mothers with lower family income
than among the wealthiest mothers.
Nonwhite mothers used up to 8.0% more iron salts
than white mothers. Women with ≤4 years of schooling
used 46.0% more iron salts than those with more educa-
tion. In addition, those with a family income ≤1-times
the minimum wage used iron more frequently (39.0%).
The adjusted analysis of other vitamins and minerals
showed that mothers who were white, more educated
and had higher incomes used more vitamins and min-
erals than any other group (Table 3).
Discussion
The findings of the present study were a 91% overall
prevalence of supplement use, a result similar to those
obtained by Forster et al. in Australia [5] and Bagheri et
al. in Iran [22], who found that 92.7% of the women
used some multivitamin during pregnancy. However, the
majority of similar studies have found lower prevalences,
ranging from 70.3 to 88.7% [23–26].
The prevalence of folic acid and iron compound use
was 70.9 and 72.9%, respectively. The use of these
supplements during pregnancy is advocated by both the
WHO and the Brazilian Ministry of Health, which rec-
ommend the use of these supplements for all pregnant
women as part of antenatal care [6, 27]. An Australian
study [5] of women in the immediate postpartum period
revealed iron and folic acid use of 52.0 and 79.0%, respect-
ively, during pregnancy, while a study from Portugal found
Fig. 1 Use of folic acid, iron salts and other vitamins and minerals among pregnant women in the Pelotas Birth Cohort (N = 4270 women).
Pelotas, RS, Brazil, 2015
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prevalence rates of 55.4 and 81.9% for iron and folic acid
use, respectively [26]. On the other hand, an Italian cohort
study of 1000 women found a prevalence of iron salt use
of 95.0% [28]. Lower prevalences of folic acid use, approxi-
mately 30.0%, were found by Mezzomo, et al. [29] and
Barbosa et al. [14] in Brazil.
With respect to iron supplementation, these differ-
ences could be attributable to different social contexts
and regional variations in recommendations, a factor
especially present in low- and middle-income countries
where dietary iron intake is often insufficient [15, 17].
Regarding the trend of iron use according to the trimester
Fig. 2 Use of folic acid, iron salts and other vitamins and minerals among pregnant women in the Pelotas Birth Cohort according to the trimester
of use and family income (N = 4270 women). Pelotas, RS, Brazil, 2015
Table 2 Prevalence of folic acid and iron salt use by pregnant women in the 2015 Pelotas Birth Cohort perinatal study, crude and
adjusted prevalence ratios and respective confidence intervals (95% CI) (N = 4270 women)
Iron salts Folic acid
Crude analysis Adjusted analysisa Crude analysis Adjusted analysisa
95% CI 95% CI 95% CI 95% CI
P (%) PR (p value) PR (p value) P (%) PR (p value) PR (p value)
Ethnicity (< 0.001) (< 0.001) (< 0.001) (0.03)
White 68.2 1 1 73.4 1 1
Other 85.8 1.25 1.20–1.31 1.11 1.07–1.16 66.6 0.90 0.85–0.96 0.97 0.91–1.03
Black 82.8 1.21 1.15–1.27 1.08 1.03–1.13 62.4 0.85 0.79–0.91 0.91 0.85–0.98
Education (years) < 0.001 < 0.001 (< 0.001) (< 0.001)c
≤ 4 years 90.6 1.72 1.61–1.83 1.46 1.36–1.56 58.6 0.71 0.65–0.79 0.78 0.71–0.86
5–8 87.4 1.66 1.56–1.75 1.45 1.35–1.53 62.7 0.77 0.72–0.81 0.82 0.77–0.87
9–11 77.3 1.46 1.38–1.56 1.31 1.23–1.40 69.9 0.86 0.82–0.89 0.88 0.84–0.93
≥ 12 52.6 1 1 81.3 1 1
Family Income b (< 0.001) (< 0.001) (< 0.001) (0.02) c
≤ 1 86.4 1.93 1.68–2.23 1.39 1.20–1.61 57.9 0.68 0.61–0.74 0.82 0.74–0.90
1.1–3.0 80.7 1.81 1.57–2.07 1.39 1.20–1.59 68.3 0.80 0.75–0.85 0.91 0.85–0,97
3.1–6.0 67.3 1.50 1.30–1.74 1.28 1.11–1.48 75.8 0.88 0.83–0.94 0.95 0.89–1.01
6.1–10.0 48.8 1.10 0.91–1.31 1.06 0.89–1.26 77.6 0.90 0.84–0.98 0.92 0.85–1.00
> 10.0 44.6 1 1 85.3 1 1
a Model adjusted for ethnicity, family income and years of education
b Monthly minimum wage in 2015 (R$788 or $201)
c p-value: χ2 test for trend
Pelotas, RS, Brazil, 2015
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of pregnancy, the increase in use in the third trimester
may be due to the fact that many mothers discover preg-
nancy and begin antenatal care with the most advanced
pregnancy, thus not having access to the recommendation
of use in the first and/or second trimester of pregnancy.
In addition, in the third trimester there are more
pregnant women with iron deficiency anemia, which
increases adherence to the recommendations of using
iron salts [27, 30, 31].
Differences in folic acid use could be due to differ-
ences between protocols. During the study period, the
current protocol in Brazil recommended the use of folic
acid in the pre-conception and during the first trimester
only [27]. However a more recent protocol recommends
the use of folic acid during all period of pregnancy [32].
In addition, this supplement is often not prescribed
when a woman’s antenatal care begins at a late stage.
However, for women seeking preconception counseling,
there is a high chance that it will be prescribed for the
all gestational period.
So, despite the fact that iron and folic acid are com-
monly prescribed in most countries, in addition to the
reasons mentioned above, nonuse by pregnant women
persists for others variety of reasons. For iron, for
example, these include adverse reactions and ignorance
of its importance [15]. There is also controversy in the
literature about the benefits and possible side effects of
iron use by non-anemic mothers [33, 34].
Consistent with the literature, we found that the use of
supplements in general was more prevalent among white
women [29, 35], older women [34, 35], those with a
higher education level [9, 14, 29] and those with a higher
income [15, 24, 29]. Although these characteristics sug-
gest some inequality, their differences were not signifi-
cant. Multiparous women used fewer supplements than
those experiencing their first pregnancy. This difference
is perhaps due to greater concern for the first child,
which diminishes somewhat with subsequent pregnan-
cies, given that prior experience and changes in attitudes
about health make the mother less insecure [15, 36].
The characteristics of folic acid, iron salt and other
vitamin and mineral use indicate that practically all sup-
plements used during antenatal care were recommended
by doctors [16, 25]. Regarding the different reasons for
use, 49.8% of women in the iron salts group were treat-
ing a deficiency, while for folic acid and other vitamins
and minerals, the most frequently reported reason was
routine prevention. This difference could be due to
increased clinical and laboratory monitoring of iron
deficiency anemia compared with that of other micronu-
trient deficiencies.
The results for the use of each supplement according
to trimester and family income are in agreement with
the findings of the stratified analysis. Regarding iron
salts, the results showed that the nonwhite, poorer and
less educated mothers used them more, which would
Table 3 Prevalence of the use of other vitamins and minerals by pregnant women in the 2015 Pelotas Birth Cohort perinatal study,
crude and adjusted prevalence ratios and respective confidence intervals (95% CI) (N = 4270 women)
Crude analysis Adjusted analysisa
P (%) PR 95% CI (p value) PR 95% CI (p value)
Ethnicity < 0.001 < 0.001
White 62.7 1 1
Other 18.3 0.49 0.41–0.58 0.77 0.65–0.91
Black 17.8 0.48 0.39–0.58 0.73 0.61–0.86
Education (years) < 0.001 < 0.001
≤ 4 years 6.9 1 1
5–8 11.7 1.70 1.10–2.64 1.50 0.97–2.33
9–11 26.0 3.80 2.50–5.73 2.91 1.91–4.43
≥ 12 59.6 8.70 5.79–13.0 5.22 3.44–7.93
Family Income b < 0.001 < 0.001
≤ 1 10.8 1 1
1.1–3.0 20.9 1.94 1.47–2.56 1.37 1.04–1.80
3.1–6.0 40.2 3.73 2.84–4.90 1.86 1.41–2.44
6.1–10.0 67.2 6.23 4.74–8.20 2.37 1.78–3.15
> 10.0 70.2 6.51 4.95–8.55 2.35 1.76–3.10
a Model adjusted for ethnicity, family income and years of education
b Monthly minimum wage in 2015 (R$788 or $201)
Pelotas, RS, Brazil, 2015
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seem to suggest that iron supplementation is more fre-
quent among poorer and nutritionally vulnerable women
going in the same direction of the results pointed out by
the study of Tomasi et al. 2017, which included all the
basic health units in Brazil and found prevalence of iron
prescriptions of almost 100% among women with the
same characteristics [12]. However the opposite has
been found in other studies [15, 16], and this difference
may be related to the fact that, in Brazil, prenatal cover-
age is considered high, and women who use public
health services the most are the poorest.
Unlike the use of iron salts, the use of folic acid and other
vitamins and minerals reflected different user profiles, i.e.,
white, wealthier and more educated [9, 13–16, 26, 35]. This
difference could be due to the fact that poorer mothers seek
health services later in pregnancy when folic acid would no
longer be recommended, whereas mothers with better
purchasing power and greater access to information would
tend to have a planned pregnancy and, thus, a greater
chance of beginning antenatal care (and supplementation)
early in T1 [15, 16].
Our study has the advantage of being a cross-sectional
study nested in a population-based cohort, which pro-
vides more timely information about supplement use.
However, it also has some limitations. No information
regarding dose or adherence was analyzed. However, the
fact that iron salts, vitamins and other minerals were
used on average 6.9 days per week can be considered a
proxy for the continuity of treatment.
The elapsed time between supplement use and the
interview can lead to recall error and underestimation of
prevalence. Nevertheless, a recent study demonstrated
good agreement between short recall periods for con-
tinuously used drugs [37]. In addition, the supplement
use data collected during antenatal care minimizes this
problem.
Since part of the sample did not participate in the
antenatal study, subgroup analyses were conducted. The
results indicated no differences in the prevalence of iron
salt use among those who participated only in the peri-
natal study. However, there was a lower prevalence of
the use of other compounds in this group. Thus, there
may have been an underestimation of the general use of
folic acid, iron salts and other vitamins and minerals
when analyzed separately.
Conclusion
This exploration of socioeconomic differences in the use
of supplements found inequalities in the use of folic acid
and other vitamins and minerals in favor of the richer
and more educated white mothers, but in the case of
vitamins and other minerals, there are no recommenda-
tions for their use or evidence of well-established bene-
fits in the pregnant population.
However, in the case of folic acid, this inequality is
relevant since it is universally recommended and has
well-established benefits. Regarding the use of iron salts,
the opposite occurred: an inequality favored nonwhite,
less educated and poorer mothers. This suggests equity
in access and demonstrates the reach of this important
public health policy.
Thus, it is concluded that the existing recommenda-
tions are sufficient, however, it is necessary that there is
an incentive to the early initiation of antenatal care,
promotion of the knowledge of the pregnant women and
the health professionals of the area on the importance of
the use of the folic acid and iron salts in the gestational
period, in order to increase the adherence to the
recommendations.
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